Identification of early proteomic markers for hepatic steatosis

Chemical Research in Toxicology

Volumn 19, Issue 8, 2006, Pages 986-998

  Meneses Lorente, G ^a,d   Watt, A ^a   Salim, K ^a   Gaskell, S J ^b   Muniappa, Nagaraja ^c   Lawrence, Jeffrey ^c   Guest, P C ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c MERCK RESEARCH LABORATORIES   (United States)

^d ROCHE PRODUCTS LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ALDEHYDE DEHYDROGENASE; ALPHA ENOLASE; AMINOTRANSFERASE; AMIODARONE; ANTIOXIDANT; BIOLOGICAL MARKER; CHAPERONE; COMPOUND CDA; CYTOCHROME B5; CYTOKERATIN 18; CYTOKERATIN 8; DRUG VEHICLE; DYNAMIN; GLUCOSE; HEAT SHOCK PROTEIN; OXIDOREDUCTASE; PROTEIN DISULFIDE ISOMERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL VACUOLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG INDUCED DISEASE; ENDOPLASMIC RETICULUM; ENZYME BLOOD LEVEL; FATTY LIVER; FEMALE; GEL ELECTROPHORESIS; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; LIVER TOXICITY; MASS SPECTROMETRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN SECRETION; RAT; STRUCTURAL PROTEOMICS;

ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FATTY LIVER; FEMALE; FLUORESCENT DYES; GENE EXPRESSION; HEPATOCYTES; MASS SPECTROMETRY; MITOCHONDRIA, LIVER; PROTEOME; PROTEOMICS; RATS; TIME FACTORS;

EID: 33748662659     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx060007f     Document Type: Article

References (47)

1. Cockerell, G. L., McKim, J. M., and Vonderfecht, S. L. (2002) Strategic importance of research support through pathology. Toxicol. Pathol. 50 (1), 4-7.
2. Wilkins, M. R., Williams, K. L., Appel, R. D., and Hochstrasser, D. F. (1997) Proteome Research: New Frontiers in Functional Genomics, Springer-Verlag, New York.
3. Mortishire-Smith, R. J., Skiles, G. L., Lawrence, J. W., Spence, S., Nicholls, A. W., Johnson, B., and Nicholson, J. K. (2003) Use of metabonomics to identify impaired fatty acid metabolism as the mechanism of a drug-induced toxicity.
4. Meneses-Lorente, G., Guest, P. C., Lawrence, J., Muniappa, N., Knowles, M. R., Skynner, H. A., Salim, K., Cristea, I., Mortishire-Smith, R., Gaskell, S. J., and Watt, A. (2004) A proteomic investigation of drug-induced steatosis in rat liver. Chem. Res. Toxicol. 17 (5), 605-612.
5. Berson, A., De Beco, V., Letteron, P., Robin, M. A., Moreau, C., El Kahwaji, J., Verthier, N., Feldmann, G., Fromentry, B., and Pessayre, D. (1998) Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes. Gastroenterology 114 (4), 764-774.
6. Fromenty, B., and Pessayre, D. (1995) Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol. Ther. 67 (1), 101-154.
7. Unlu, M., Morgan, M. E., and Minden, J. S. (1997) Difference gel electrophoresis. A single gel method for detecting changes in protein extracts. Electrophoresis 18 (11), 2071-2077.
8. Knowles, M. R., Cervino, S., Skynner, H. A., Hunt, S. P., de Felipe, C., Salim, K., Meneses-Lorente, G., McAllister, G., and Guest, P. C. (2003) Multiplex proteomic analysis by two-dimensional differential in-gel electrophoresis. Proteomics 3 (7), 1162-1171.
9. Strom, S. C., Jirtle, R. L., Jones, R. S., Novicki, D. L., Rosenberg, M. R., Novotny, A., Irons, G., McLain, J. R., and Michalopoulos, G. (1982) Isolation, culture, and transplantation of human hepatocytes. J. Natl. Cancer Inst. 68 (5), 771-778.
10. Greenspan, P., Mayer, E. P., and Fowler, S. D. (1985) Nile red: a selective fluorescent stain for intracellular lipid droplets. J. Cell Biol. 100 (3), 965-973.
11. McMillian, M. K., Grant, E. R., Zhong, Z., Parker, J. B., Li, L., Zivin, R. A., Burczynski, M. E., and Johnson, M. D. (2001) Nile Red binding to HepG2 cells: an improved assay for in vitro studies of hepatosteatosis. In Vitro Mol. Toxicol. 14 (3), 177-190.
12. Kasugai, S., Hasegawa, N., and Ogura, H. (1990) A simple in vito cytotoxicity test using the MTT (3-(4,5)-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) colorimetric assay: analysis of eugenol toxicity on dental pulp cells (RPC-C2A). Jpn. J. Pharmacol. 52 (1), 95-100.
13. Molloy, M. P., Herbert, B. R., Walsh, B. J., Tyler, M., I. Traini, M., Sanchez, J. C., Hochstrasser, D. F., Williams, K. L., and Gooley, A. A. (1998) Extraction of membrane proteins by differential solubilization for separation using two-dimensional gel electrophoresis. Electrophoresis 19 (5), 837-844.
14. Wilm, M., and Mann, M. (1996) Analytical properties of the nanoelectrospray ion source. Anal. Chem. 68 (1), 1-8.
15. Raponi, M., Belly, R. T., Karp, J. E., Lancet, J. E., Atkins, D., and Wang, Y. (2004) Microarray analysis reveals genetic pathways modulated by tipifarnib in acute myeloid leukemia. BMC Cancer 4, 56.
16. Siripurapu, V., Meth, J., Kobayashi, N., and Hamaguchi, M. (2005) DBC2 significantly influences cell-cycle, apoptosis, cytoskeleton and membrane-trafficking pathways. J. Mol. Biol. 346 (1), 83-89.
17. Hsu, H., Xiong, J., and Goeddel, D. V. (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 81 (4), 495-504.
18. Bruccoleri, A., Gallucci, R., Germolec, D. R., Blackshear, P., Simeonova, P., Thurman, R. G., and Luster, M. I. (1997) Induction of early-immediate genes by tumor necrosis factor alpha contribute to liver repair following chemical-induced hepatotoxicity. Hepatology 25 (1), 133-141.
19. Runnegar, M. T., Andrews, J., Gerdes, R. G., and Falconer, I. R. (1987) Injury to hepatocytes induced by a peptide toxin from the cyanobacterium Microcystis aeruginosa. Toxicon 25 (11), 1235-1239.
20. Falconer, I. R., and Yeung, D. S. (1992) Cytoskeletal changes in hepatocytes induced by Microcystis toxins and their relation to hyperphosphorylation of cell proteins. Chem.-Biol. Interact. 81 (1-2), 181-196.
21. Wickstrom, M. L., Khan, S. A., Haschek, W. M., Wyman, J. F., Eriksson, J. E., Schaeffer, D. J., and Beasley, V. R. (1995) Alterations in microtubules, intermediate filaments, and microfilaments induced by microcystin-LR in cultured cells. Toxicol. Pathol. 23 (3), 326-337.
22. Grossmann, E. M., Longo, W. E., Kaminski, D. L., Smith, G. S., Murphy, C. E., Durham, R. L., Shapiro, M. J., Norman, J. G., and Mazuski, J. E. (2000) Clostridium difficile toxin: cytoskeletal changes and lactate dehydrogenase release in hepatocytes. J. Surg. Res. 88 (2), 165-172.
23. Aliprantis, A. O., Yang, R. B., Weiss, D. S., Godowski, P., and Zychlinsky, A. (2000) The apoptotic signaling pathway activated by Toll-like receptor-2. EMBO J. 19 (13), 3325-3336.
24. Ulrich, R., and Friend, S. H. (2002) Toxicogenomics and drug discovery: will new technologies help us produce better drugs? Nat. Rev. Drug Discovery 1 (1), 84-88.
25. Massey, L. K., Sokatch, J. R., and Conrad, R. S. (1976) Branched-chain amino acid catabolism in bacteria. Bacteriol. Rev. 40 (1), 42-54.
26. Reed, L. J., Fernandez-Moran, H., Koike, M., and Willms, C. R. (1964) Electron microscopic and biochemical studies of pyruvate dehydrogenase complex of Escherichia coli. Science 145, 930-932.
27. Robson, K. J. H., Chandra, T., MacGillivray, R. T. A., and Woo, S. L. C. (1982) Polysome immunoprecipitation of phenylalanine hydroxylase mRNA from rat liver and cloning of its cDNA. Proc. Natl. Acad. Sci. U.S.A. 79 (15), 4701-4705.
28. Dzhivanian, K. A., and Ter Oganian, K. S. (1979) [Nonspecific esterase and alpha-glycerolphosphate dehydrogenase activity and the fat content in the regenerating chicken liver], Biull. Eksp. Biol. Med. 87 (6), 547-550.
29. Stein, T. A., Burns, G. P., Tropp, B. E., and Wise, L. (1985) Hepatic fat accumulation during liver regeneration. J. Surg. Res. 39 (4), 338-343.
30. Ragazzi, E., Costa, C. V., Caparrotta, L., Biasiolo, M., Bertazzo, A., and Allegri, G. (2002) Enzyme activities along the tryptophan-nicotinic acid pathway in alloxan diabetic rabbits. Biochim. Biophys. Acta 1571 (1), 9-17.
31. Van Greevenbroek, M. M., Vermeulen, V. M., and De Bruin, T. W. (2004) Identification of novel molecular candidates for fatty liver in the hyperlipidemic mouse model, HcB19. J. Lipid Res. 45 (6), 1148-1154.
32. Skrede, S., Sorensen, H. N., Larsen, L. N., Steineger, H. H., Hovik, K., Spydevold, O. S., Horn, R., and Bremer, J. (1997) Thia fatty acids, metabolism and metabolic effects. Biochim. Biophys. Acta 1344 (2), 115-131.
33. Nakamuta, M., Kohjima, M., Morizono, S., Kotoh, K., Yoshimoto, T., Miyagi, I., and Enjoji, M. (2005) Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. Int. J. Mol. Med. 16 (4), 631-635.
34. Kraus, J. P., Kalousek, F., and Rosenberg, L. E. (1983) Biosynthesis and mitochondrial processing of the beta subunit of propionyl coenzyme A carboxylase from rat liver. J. Biol. Chem. 258 (12), 7245-7248.
35. Miyazaki, T., Ohura, T., Kobayashi, M., Shigematsu, Y., Yamaguchi, S., Suzuki, Y., Hata, I., Aoki, Y., Yang, X., Minjares, C., Haruta, I., Uto, H., Ito, Y., and Muller, U. (2001) Fatal propionic acidemia in mice lacking propionyl-CoA carboxylase and its rescue by postnatal, liver-specific supplementation via a transgene. J. Biol. Chem. 276 (38), 35995-35999.
36. Ferre, N., Camps, J., Cabre, M., Paul, A., and Joven, J. (2001) Hepatic paraoxonase activity alterations and free radical production in rats with experimental cirrhosis. Metab., Clin. Exp. 50 (9), 997-1000.
37. Weber, L. W., Boll, M., and Stampfl, A. (2003) Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit. Rev. Toxicol. 33 (2), 105-136.
38. Jones, S. M., Howell, K. E., Henley, J. R., Cao, H., and McNiven, M. A. (1998) Role of dynamin in the formation of transport vesicles from the trans-Golgi network. Science 279 (5350), 573-577.
39. Shih, D. M., Gu, L., Xia, Y. R., Navab, M., Li, W. F., Hama, S., Castellani, L. W., Furlong, C. E., Costa, L. G., Fogelman, A. M., and Lusis, A. J. (1998) Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 394 (6690), 284-287.
40. Loranger, A., Duclos, S., Grenier, A., Price, J., Wilson-Heiner, M., Baribault, H., and Marceau, N. (1997) Simple epithelium keratins are required for maintenance of hepatocyte integrity. Am. J. Pathol. 151 (6), 1673-1683.
41. Nakamichi, I., Hatakeyama, S., and Nakayama, K. I. (2002) Formation of Mallory body-like inclusions and cell death induced by deregulated expression of keratin 18. Mol. Biol. Cell 13 (10), 3441-3451.
42. Toivola, D. M., Ku, N. O., Resurreccion, E. Z., Nelson, D. R., Wright, T. L., and Omary, M. B. (2004) Keratin 8 and 18 hyperphosphorylation is a marker of progression of human liver disease. Hepatology 40 (2), 459-466.
43. Amacher, D. E. (1998) Serum transaminase elevations as indicators of hepatic injury following the administration of drugs. Regul. Toxicol. Pharmacol. 27 (2), 119-130.
44. Graham, D. J., Green, L., Senior, J. R., and Nourjah, P. (2003) Troglitazone-induced liver failure: a case study. Am. J. Med. 114 (4), 299-306.
45. Pessayre, D., Bichara, M., Degott, C., Potet, F., Benhamou, J. P., and Feldmann, G. (1979) Perhexiline maleate-induced cirrhosis. Gastroenterology 76 (1), 170-177.
46. Simon, J. B., Manley, P. N., Brien, J. F., and Armstrong, P. W. (1984) Amiodarone hepatotoxicity simulating alcoholic liver disease. N. Engl. J. Med. 311 (3), 167-172.
47. Zimmerman, H. J. (1978) Hepatotoxicity: The Adverse Effects of Drugs and Other Chemicals on the Liver, Appleton-Century-Crofts, New York.